← back to search

Liis Haljasmägi

University of Tartu ·
Area of research
Infectious Diseases · Rheumatology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Systemic Lupus Erythematosus Research, and Long-Term Effects of COVID-19.
h-index
17
citations
5,989
works
41
NIH funding
primary concept
Medicine
email

Recent publications

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature
Science Immunology 2025cited by 14position: middledoi
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia
Journal of Interferon & Cytokine Research 2023cited by 27position: middledoi
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences 2022cited by 188position: middledoi
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Science Immunology 2021cited by 624position: middledoi
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science 2020cited by 2,832position: middledoi
A dynamic COVID-19 immune signature includes associations with poor prognosis
Nature Medicine 2020cited by 1,028position: middledoi
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
Scientific Reports 2020cited by 92position: firstdoi
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Nature Medicine 2020cited by 68position: middledoi
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Nature Medicine 2020cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pärt Peterson · University of Tartu2 papers (2020–2023)Kai Kisand · University of Tartu2 papers (2020–2023)Quentin Philippot · Inserm1 papers (2023–2023)Sofie E. Jørgensen · Aarhus University1 papers (2023–2023) · 1 papers (2023–2023)Tracy Hussell · Manchester Academic Health Science Centre1 papers (2023–2023) · 1 papers (2020–2020)Qian Zhang · BGI Group (China)1 papers (2023–2023) · 1 papers (2020–2020) · 1 papers (2020–2020)Madhvi Menon · University of Manchester1 papers (2023–2023)Trine H. Mogensen · Texas A&M University1 papers (2023–2023) · 1 papers (2020–2020)Anne Puel · Inserm1 papers (2023–2023) · 1 papers (2020–2020)Arnaud Fekkar · Hospital for Sick Children1 papers (2023–2023) · 1 papers (2023–2023)Shen‐Ying Zhang · Inserm1 papers (2023–2023) · 1 papers (2020–2020) · 1 papers (2023–2023)